EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Patient Dosing in the Second Cohort Has Commenced Following the Successful Completion of the First Cohort'
独家:adial pharmaceuticals告诉Benzinga:“第二组患者的服药量开始了,第一组的治疗成功结束。”
EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Patient Dosing in the Second Cohort Has Commenced Following the Successful Completion of the First Cohort'
独家:adial pharmaceuticals告诉Benzinga:“第二组患者的服药量开始了,第一组的治疗成功结束。”
使用浏览器的分享功能,分享给你的好友吧